Frevecitinibum
Frevecitinibum (Frevecitinib) is a Janus kinase inhibitor, with anti-inflammatory effect[1].
Product Specifications
CAS Number
1299417-07-4
Product Name Alternative
Frevecitinib
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/frevecitinibum.html
Smiles
O=C1N([C@@H]2CN(CCC2)C(CC#N)=O)C3=NC(C4=C5N(C=CC=C5)N=C4)=CC=C3N1C
Molecular Formula
C22H21N7O2
Molecular Weight
415.45
References & Citations
[1]Frevecitinibum (Frevecitinib) . WHO Drug Information, Vol. 37, No. 4, 2023.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15237183 1 Vial
Lentiviral mouse Dpp6 shRNA (UAS) - Lentiviral mouse Dpp6 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details RC215328L2V 200 µL
PEG3 (NM_006210) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 